In collaboration with pioneering academic researchers and pharma partners, Inception Sciences has created multiple new start-up companies for translating breakthrough scientific insights into novel therapies.
Development of a novel product candidate for fibrotic disease, in partnership with Shire Pharmaceuticals.
Development of novel therapies for oncology and other therapeutic areas.
Discovering novel treatments for sensorineural hearing loss, in partnership with Roche. Nominated for 2012 Alliance Deal of the Year by In Vivo.
Development of innovative therapeutics for patients with eye diseases, in partnership with Bayer.
Development of novel small molecule remyelinating therapies for patients with multiple sclerosis, in partnership with Roche.